Connection
Muthu Veeraputhiran to Graft vs Host Disease
This is a "connection" page, showing publications Muthu Veeraputhiran has written about Graft vs Host Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.395 |
|
|
|
-
Pusic I, Lee C, Veeraputhiran M, Minor C, DiPersio JF. Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease. Bone Marrow Transplant. 2024 02; 59(2):282-284.
Score: 0.221
-
Kakadia S, Trotta H, Kurczek L, Burdine L, Veeraputhiran M, Giorgakis E. Early Outcomes of Ruxolitinib in the Treatment of Steroid Refractory Graft-versus-host Disease on Liver Transplant Recipients. Transplantation. 2020 08; 104(8):e247.
Score: 0.175